The Italian startup BCI – BioCompatibility has developed a new technology which is able to double the duration of biological heart valves thanks to the implementation of naturally derived active ingredients.
The financing strongly contributed to the implementation of the project: «We achieved the results thanks to who believed in us and financed the project, otherwise we wouldn’t have made it» explained Alessandro Gandaglia, CEO of BCI.
Read the full article